REGENXBIO, Inc. (RGNX)
7.16
+0.28
(+4.07%)
USD |
NASDAQ |
Oct 15, 16:00
7.11
-0.05
(-0.70%)
After-Hours: 20:00
REGENXBIO Cash from Operations (TTM) : -246.67M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -246.67M |
| March 31, 2026 | -233.78M |
| December 31, 2025 | -123.96M |
| September 30, 2025 | -103.30M |
| June 30, 2025 | -87.89M |
| March 31, 2025 | -84.04M |
| December 31, 2024 | -173.12M |
| September 30, 2024 | -182.26M |
| June 30, 2024 | -191.12M |
| March 31, 2024 | -192.94M |
| December 31, 2023 | -218.41M |
| September 30, 2023 | -217.02M |
| June 30, 2023 | -218.07M |
| March 31, 2023 | -232.50M |
| December 31, 2022 | -207.49M |
| September 30, 2022 | 158.12M |
| June 30, 2022 | 172.22M |
| March 31, 2022 | 204.10M |
| December 31, 2021 | 218.88M |
| September 30, 2021 | -67.89M |
| June 30, 2021 | -68.00M |
| March 31, 2021 | -59.62M |
| Date | Value |
|---|---|
| December 31, 2020 | -54.06M |
| September 30, 2020 | -119.04M |
| June 30, 2020 | -111.73M |
| March 31, 2020 | -113.98M |
| December 31, 2019 | -107.70M |
| September 30, 2019 | -86.34M |
| June 30, 2019 | -76.74M |
| March 31, 2019 | 17.22M |
| December 31, 2018 | 104.65M |
| September 30, 2018 | 94.96M |
| June 30, 2018 | 97.38M |
| March 31, 2018 | 17.62M |
| December 31, 2017 | -57.99M |
| September 30, 2017 | -64.59M |
| June 30, 2017 | -59.27M |
| March 31, 2017 | -58.15M |
| December 31, 2016 | -48.56M |
| September 30, 2016 | -32.58M |
| June 30, 2016 | -29.12M |
| March 31, 2016 | -28.69M |
| December 31, 2015 | -22.48M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| AbbVie, Inc. | 19.51B |
| United Therapeutics Corp. | 1.682B |
| Ardelyx, Inc. | -17.32M |
| Biomea Fusion, Inc. | -47.06M |
| RenovoRx, Inc. | -11.87M |